Dimitrios Doultsinos
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.
Journal: EMBO molecular medicine
Published: June 04, 2025
IGF-1 regulates cancer cell immune evasion in prostate cancer.
Journal: Scientific reports
Published: March 15, 2025
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures.
Journal: Molecular cancer
Published: June 12, 2023
Accelerated and intensified manufacturing of an adenovirus-vectored vaccine to enable rapid outbreak response.
Journal: Biotechnology and bioengineering
Published: April 20, 2023
A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment.
Journal: iScience
Published: December 01, 2022
Dual IRE1 RNase functions dictate glioblastoma development.
Journal: EMBO molecular medicine
Published: August 12, 2022
Dual IRE1 RNase functions dictate glioblastoma development.
Journal: EMBO molecular medicine
Published: December 20, 2021
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.
Journal: RNA biology
Published: October 01, 2021
Spatially resolved clonal copy number alterations in benign and malignant tissue.
Journal: Nature
Published: July 23, 2021
Last Updated: 09/26/2026